APA

Zawistowski J. S., Bevill S. M., Goulet D. R., Stuhlmiller T. J., Beltran A. S., Olivares-Quintero J. F., Singh D., Sciaky N., Parker J. S., Rashid N. U., Chen X., Duncan J. S., Whittle M. C., Angus S. P., Velarde S. H., Golitz B. T., He X., Santos C., Darr D. B., Gallagher K., Graves L. M., Perou C. M., Carey L. A., Earp H. S. & Johnson G. L. (20171219). Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex. : Cancer discovery.

Chicago

Zawistowski Jon S, Bevill Samantha M, Goulet Daniel R, Stuhlmiller Timothy J, Beltran Adriana S, Olivares-Quintero Jose F, Singh Darshan, Sciaky Noah, Parker Joel S, Rashid Naim U, Chen Xin, Duncan James S, Whittle Martin C, Angus Steven P, Velarde Sara Hanna, Golitz Brian T, He Xiaping, Santos Charlene, Darr David B, Gallagher Kristalyn, Graves Lee M, Perou Charles M, Carey Lisa A, Earp H Shelton and Johnson Gary L. 20171219. Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex. : Cancer discovery.

Harvard

Zawistowski J. S., Bevill S. M., Goulet D. R., Stuhlmiller T. J., Beltran A. S., Olivares-Quintero J. F., Singh D., Sciaky N., Parker J. S., Rashid N. U., Chen X., Duncan J. S., Whittle M. C., Angus S. P., Velarde S. H., Golitz B. T., He X., Santos C., Darr D. B., Gallagher K., Graves L. M., Perou C. M., Carey L. A., Earp H. S. and Johnson G. L. (20171219). Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex. : Cancer discovery.

MLA

Zawistowski Jon S, Bevill Samantha M, Goulet Daniel R, Stuhlmiller Timothy J, Beltran Adriana S, Olivares-Quintero Jose F, Singh Darshan, Sciaky Noah, Parker Joel S, Rashid Naim U, Chen Xin, Duncan James S, Whittle Martin C, Angus Steven P, Velarde Sara Hanna, Golitz Brian T, He Xiaping, Santos Charlene, Darr David B, Gallagher Kristalyn, Graves Lee M, Perou Charles M, Carey Lisa A, Earp H Shelton and Johnson Gary L. Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex. : Cancer discovery. 20171219.